Tuesday, November 22, 2011

Hothouse Earth Is On The Horizon


An era of ice that has gripped Earth's poles for 35 million years could come to an end as extreme global warming really begins to bite. Previously unknown sources of positive feedback — including "hyperwarming" that was last seen on Earth half a billion years ago— may push global temperatures high enough to send Earth into a hothouse state with tropical forests growing close to the poles.
Climate scientists typically limit themselves to the 21st century when predicting how human activity will affect global temperatures. The latest predictions are bolder, though: the first systematic forecasts through to 2300 are beginning to arrive. They follow four possible futures, including one in which we rapidly cut emissions and another in which we burn fossil fuels into the 22nd century (Climatic Change, DO!: 10.1007/ s1o584-011-0157-y).
Chris Jones of the UK Met Office in Exeter says that unpublished results suggest the "burn everything" scenario could see atmospheric carbon dioxide levels reach 2000 parts per million—the figure today is 388 ppm. That pulse of CG, could lead to a global temperature rise of 10°C. Temperatures this high were last seen in the Eocene, 34 million years ago, says Paul Pearson of Cardiff University in the UK. Conditions were so different back then that the Canadian High Arctic was populated by plants that are now found in the south-eastern US (Proceedings of the Royal Society B, DO!: 10.1098/ rspb.2011.1704).
The Eocene marked the end of a hothouse that had begun in the Cretaceous (see chart). Throughout this time there was no ice at the poles; Antarctica was once populated by dinosaurs. Might the predicted rise in temperature be enough to see a return to an ice-free world?
The poles will warm much more than the tropics, says Tim Lenton of the University of Exeter, UK, so the Arctic could well lose all its ice. But Antarctic ice would probably survive, thinks Andrew Watson of the University of East Anglia, in Norwich, UK, because Antarctica is isolated from the rest of the continents.
In fact, Antarctica may have gained its ice when it became cut off from Australia during the Eocene and lost the warming influence of equatorial currents. Plate tectonic models predict that Antarctica will remain isolated from the other continents for at least the next 250 million years (New Scientist, 17 September, p 16). Even so, Antarctica's icy future may not be secure. The long-term climate models that go up to the year 2300 are missing key positive feedbacks that could send global temperatures towards levels high enough to melt even an isolated Antarctica.
In particular, the release of methane from melting Arctic permafrost has not yet been factored in. Methane is a potent greenhouse gas, but remains in the atmosphere for only to years on average before it reacts with hydroxyl radicals in the air to form CO,. However, a large release of methane from melting permafrost could swamp the hydroxyl supply, allowing the methane to linger in the atmosphere for 15 years or more, further amplifying the warming (Global Biogeochemical Cycles, DOI: to.1029/2010GB003845). Some feedbacks never before considered might also come into play. Pearson says that in the future oceans may store less carbon. Normally some atmospheric carbon is lost at sea, buried in the carcasses of tiny marine animals. But sediment from the Eocene contains little carbon, suggesting that this process failed during the last hothouse (Paleoceanography, DOT: 10.1029/2005PA0o123o).
To work out why, Pearson looked at fossils of foraminifera, microscopic shelled marine animals. The tiny shells contain a chemical record of the position the animals occupied in the water column when they were alive. He found that Eocene foraminifera lived closer to the ocean surface than they do today, suggesting there was little food to sustain deeper-dwelling species.
Pearson thinks the warmer temperatures allowed bacteria at the ocean surface to metabolise faster, recycling carbon before it could sink and feed foraminifera living at depth. "if we warm the planet now, we switch on our bacteria," he said last month at a Royal Society discussion meeting in London.
A warming climate will also see trees and other large plants spreading north into the Arctic, says Bette Otto-Bliesner of the US National Center for Atmospheric  Research in Boulder, Colorado, who also attended last month's Royal Society event. Plants are darker than snow, so they absorb more of the sun's radiation. When Otto-Bliesner plugged the effect into a climate model of the Arctic, it got 3°C warmer.
Then there's hypenvarming. Ed Landing of the New York State Museum in Albany coined the term to describe the spiralling temperatures seen during the Cambrian period as a result of rising sea levels. Vast areas of the continents were covered with shallow seas during the Cambrian, which began 542 million years ago, because sea levels were sometimes tens of metres higher than today. Sea water absorbs more of the sun's heat than land, so swamping the continents caused the planet to warm up even more. Sea temperatures reached 40°C and oxygen levels in the water crashed (Palaeogeography, Palaeoclimatology, Pa laeoecology, DOI: to.1p16/j.palaeo.2o11.o9.005).
Something similar could happen again today. "These effects will operate as sea level rises to an appreciable degree and floods continental areas," agrees Thomas Algeo of the University of Cincinnati in Ohio. However, the effect today may not be as strong as it was in the Cambrian, says Lee Kump of Pennsylvania State University in University Park. There were no land plants back then, so the continents were more reflective and flooding them had a bigger effect.
Pearson and Landing's processes have not yet been plugged into any climate models so we do not know how significant they will be to our future. Pearson emphasises that hothouse Earth is far from inevitable. "We can prevent this happening," he says. But as researchers dig deeper into the factors that influence global climate, it is becoming increasingly clear that global warming might be about to get much more extreme.
SOURCE : NEW SCIENTIST MAGAZINE NOVEMBER 2011

See Beyond The Light To Find Future Disease

DEEP in the heart of the cell, your DNA may be undergoing subtle changes that could lead to a devastating disease several years down the line. New microscopy techniques are now lifting the lid on this inner world, potentially offering an early-warning system for cancer or Alzheirner's long before the diseases begin to bite.
Full-blown disease may be preceded by a long build-up. For example, a change in chromatin — the complex of DNA and proteins that packages DNA into the cell nucleus— is one of the earliest events to occur after exposure to carcinogens or ultraviolet rays. Changes sometimes happen years before symptoms of a tumour manifest themselves.
 However, tracking those changes has been frustratingly beyond the reach of medicine. They involve tweaks to structures that are less than 400 nanometres across, which is smaller than the wavelength of the visible light used in ordinary optical microscopy.
"When you have two structures that are smaller than the wavelength of light, you can't really tell them apart and everything is merged into one big blur," says Vadim Backman of Northwestern University in Evanston, Illinois. "We're missing all that complexity!' To make sense of the blur, Backman has ditched standard microscopes in favour of a method called partial wave spectroscopic (PWS) microscopy.
PWS looks at how a light beam interacts with a cell. As the beam travels through the cell it reflects off different structures within according to their density. The pattern from the reflected light is used to reconstruct the nanoscale detail inside the cell.
"It's almost like you have a cat in a black box. Instead of trying to X-ray it, you hear it miaow and so you know it is a cat," says Backman, who presented his work at the Frontiers in Cancer Prevention Research meeting in Boston last month. PWS is one of many new techniques for studying cells at the nanoscale.
It is particularly good at detecting changes in density in complexes like chromatin. So far, Backman has used PWS to show that apparently healthy cells taken from people with lung, colon, pancreatic, ovarian and oesophageal cancer have unusual chromatin densities not seen in cells from people who are cancer-free. What's more, such changes are relatively easy to detect because they often occur in normal cells as well as those that are or will become cancerous.
For example, Backman used PWS to identify which of 135 smokers had lung cancer and which were cancer-free by analysing cells swabbed from the inside of the cheek (Cancer Research, DO!: 10.1158/0008-5472. can-10-1686). Similarly, he found that a swab of rectal cells could identify people with colon cancer, and a cervical swab could detect women with ovarian cancer. "It is a very creative and promising method," says Igor Sokolov of Clarkson University in Potsdam, New York, who is using another nanoscale technique called atomic force microscopy to look for differences between healthy and cancerous cervical cells.
"Anything that provides new information about cellular structure at the nanoscale will potentially be advantageous for both diagnostics and further understanding of diseases." The hope is that PWS could be used to screen the general population for early signs of cancer. Backman also has preliminary evidence that PWS could be used to diagnose autoimmune diseases such as inflammatory bowel syndrome and to investigate the changes in cells that cause Alzheimer's disease to develop.

SOURCE : NEW SCIENTIST MAGAZINE NOVEMBER 2011

Brain Doping


MOST of us want to reach our full potential. We might drink a cup of coffee to stay alert, or go for a run to feel on top of the job. So where's the harm in taking a pill that can do the same thing?
So-called cognitive-enhancing drugs are usually prescribed to treat medical conditions, but they are also known for their ability to improve memory or focus. Many people buy them over the internet, which is risky because they don't know what they are getting. We also know next to nothing about their long-term effects on the brains of healthy people, particularly the young. But some scientists believe they could have a beneficial role to play in society, if properly regulated.
So who's taking what? The BBC's flagship current affairs show Newsnight and New Scientist ran an anonymous online questionnaire to find out. I also decided to try a cognitive enhancer for myself.
 The questionnaire was completed by 761 people, with 38 per cent saying they had taken a cognitive-enhancing drug at least once. Of these, nearly 40 per cent said they had bought the drug online and 92 per cent said they would try it again. Though not representative of society, the survey is an interesting, anecdotal snapshot of a world for which there is little data.
 The drugs people said they had taken included modafinil, normally prescribed for sleep disorders, and Ritalin and Adderall, taken for ADHD. The range of experiences is striking. One respondent wrote: "It helps me extend my concentration. I can study a topic for six hours, for example, that would have me bored to tears in two." Another wrote: "Did not help me do anything but feel anxious and excited, could not sit still even 15 hours later."
 When asked about the drugs' potential impact on society, people reported concerns beyond safety, for example warning that the drugs might create a two-tier education system in which some can afford the drugs and others can't. They voiced wider concerns too, such as: "If society has come to the point that we have to take cognitive enhancers to function or perform to certain expected levels, then it is a society that has placed performance over happiness and health."
Laurie Pycroft, a student at the University of Oxford, talked to Newsnight about his experiences with modafinil. "I've taken it a few times, primarily for its ability to increase wakefulness and allow me to concentrate and stay awake for very extended periods of time. I don't take it very often but if I want to stay awake for zo or 30 hours working on an essay it's very useful," he said.
Keen to learn more, I contacted Barbara Sahakian, a neuroscientist at the University of Cambridge. She and her team work with people who have conditions such as Alzheimer's and Parkinson's disease. One area of their research is testing whether cognitive-enhancing drugs such as modafinil help. Sahakian thinks these drugs could play a wider role in society.
Her most recent research showed that sleep-deprived surgeons performed better on modafinil. "I do think we've undervalued [the drugs]. As a society we could perhaps move fonvard if we all had a form of cognitive enhancement that was safe," she told me. Before I could self-experiment with the drug! had to satisfy Sahakian's colleague James Rowe that there were no risks. We also had trained medical staff nearby. I took a tablet on two separate days without knowing which one was modafinil and which was a placebo. I then did an hour or so of tests involving memory, strategy, planning and tests of impulsiveness.
On the second day I felt more focused and in control and thought I performed better in the tests. That was the day I had been given modafinil. Rowe summed up my performance: "What we've seen today is some very striking improvements.., in memory and, for example, your planning abilities and on impulsivity." It's human nature to want to push against our limitations, but what about the risks? Before sanctioning a drug as a cognitive enhancer for healthy people, regulators would require long-term safety studies so they could weigh up the risks and benefits.
Pharmaceutical companies are not rushing to carry out such studies, but Sahakian is calling for such work to be done before someone comes to harm. Some cognitive enhancers, such as Ritalin, are controlled drugs. Modafinil is not, so it is legal to buy it online, though it is illegal to supply it without a prescription. The UK government, through the Medicines and Healthcare products Regulatory Agency, told Newsnight that tackling the illegal sale and supply of medicines over the Internet is a priority. It's not just students who claim to find the drug beneficial.
Anders Sandberg of the Future of Humanity Institute at the University of Oxford talks openly about using cognitive-enhancing drugs. He is about to start a study in Germany to compare the effects of a range of cognitive enhancers, including two hormones —ghrelin, which promotes hunger, and oxytocin, which is associated with empathy—to test their powers at what he calls "moral enhancement".
"Once we have figured out how morality works as an emotional and mental system there might be ways of improving it," he told me. The bottom line is that cognitive-enhancing pills are a reality and people are using them. But how comfortable are we with the knowledge that some of our children's classmates might be taking such drugs to perform better at school, or that one candidate for a job interview might use modafin i I to outshine the others? And who was the real me, the one on modafinil, or the one not? Perhaps we should start thinking these questions through, before a drug offering far more than a few percentage points of enhancement comes our way.
SOURCE : NEW SCIENTIST MAGAZINE NOVEMBER 2011

Monday, November 21, 2011

Liquid Power For Chips

GETTING microchips wet is normally best avoided. But a new type of chip that is both powered and cooled by fluid pumping through it could power the computers, srnartphones and tablets of the future. If the design is successful, its inventors at IBM argue an entire supercomputer—like Watson, the firm's natural-language-processing trivia savant— could one day be squeezed onto mobile devices small enough to fit in your pocket.
The idea is inspired by the way the human brain is powered, says Bruno Michel, who is leading the work at IBM's Zurich Research Laboratory in Switzerland. "The human brain is 10,000 times more dense and efficient than any computer today. That's possible because it uses only one, extremely efficient, network of capillaries and blood vessels to transport heat and energy, all at the same time," he says.
Michel and his team's idea is to stack hundreds of silicon wafers on top of each other to create three-dimensional processors. Between each layer is a pair of fluidic networks. One of these carries in charged fluid to power the chip, while the second carries away the same fluid after it has picked up heat from the active transistors —effectively creating a microscopic flow battery.
Chips in 3D have already been  developed. Intel's Ivy Bridge processors, which are expected to appear in consumer products next year, will use vertical transistors to allow more components to be crammed into a given area, yielding many times the processing power of conventional 2D chips. Intel has also dabbled with stacking microchips on top of each other, as have other chip manufacturers including Belgium-based IMEC and Tezzaron in Illinois."The use of liquid to cool 3D chips is not new," says Bob Patti, chief technology officer of Tezzaron. "However, using the liquid as a power source as well as for cooling is a concept I haven't seen before!' Mark Zwolinski at the University of Southampton, UK, agrees it's an interesting approach. "To get increases in high-performance computing it's going to be necessary to move chips closer together," he says, and that means stacking them. But powering them with liquid is uncharted territory, he says. "It's not completely outrageous. I can't think why it shouldn't work, but it has never been done before!' It had better work, says Michel, because the computing industry has for decades depended on computer chips to double in processing power approximately every two years—the phenomenon known as Moore's law. But as transistors on conventional chips have shrunk, so too have the wires connecting them, increasing their resistance and making them less energy-efficient.
It takes about 85 kilowatts to run Watson, for example—enough to heat a dozen homes. And the machine's servers take up the same amount of space as to large refrigerators.
Using this biologically inspired approach to combine the electrical and cooling systems into one should make it possible to reduce that power consumption considerably. Michel says he and his colleagues have demonstrated that it is possible to use a liquid to transfer power via a network of fluidic channels, and they plan build a working prototype chip by 2014. If successful, we could end up with Watsons in our pockets, powered by a battery akin to that found in a cellphone.
SOURCE : NEW SCIENTIST MAGAZINE NOVEMBER 2011

Sunday, November 20, 2011

Ethical and Plentiful Stem Cells From Milk

Embryonic-like stein cells have been discovered in breast milk in large numbers. This is the first time such cells have been found in an adult. If the cells live up to their potential we may soon have stem cells for medical therapy, without destroying any embryos.
Back in 2008, Peter Hartrnann at the University of Western Australia in Crawley and his colleagues announced they had discovered stem cells in breast milk. Crucially, these cells have now been turned into the kind that represent all three embryonic germ layers —the endoderm, mesoderm and  ectoderm — a defining property of embryonic stem cells (ESCs). "They can become bone cells, joint cells, pancreatic cells that produce their own insulin, liver cells that produce albumin, and neuronal cells," says Foteini Hassiotou of Hartmann's team, who led the recent work.
The cells also express the majority of protein markers that you would expect to find in ESCs. "What is really amazing is that these cells can be obtained in quite large amounts in breast milk," Hassiotou adds.
She says the stein cells make up around 2 per cent of cells in breast milk, although the number varies according to how long the woman has been producing milk and how full her breasts are. Hassiotou will present the work early next year at the 7th International Breastfeeding and Lactation Symposium in Vienna, Austria.
Many researchers remain sceptical. "Perhaps there are some mammary gland stem cells that can be coaxed to have a broader potential, but! very much doubt that embryonic-like cells normally exist in the breast," says Robin Lovell-Badge of the UK's National Institute for Medical Research in London.
The real test will be to inject these cells into mice and see if they form teratomas — tumours containing tissue or structures derived from all three germ layers. "That's the gold standard for whether you have a true pluripotent cell," says Chris Mason of University College London. Hassiotou says they will start these tests in coming weeks.
Embryonic-like stem cells have been found in amniotic fluid and the umbilical cord, but never before in adults. Other adult stem cells exist, such as those that can generate blood or turn into bone, fat and cartilage cells. But these stem cells cannot generate as many cell types as the breast milk cells appear to. "If they are truly embryonic, this would be another way of getting stem cells that would not raise ethical concerns," says Mason.
Even if they do not turn out to be ESCs, these breast milk cells could still have great potential for regenerative medicine. "It might be possible to grow these cells then bank them so that if or when t he mother develops some disease later in life, such as diabetes, her cells may be defrosted and differentiated into pancreatic beta cells," says Lyle Armstrong of Newcastle University, UK, although he cautions that more tests are needed to determine exactly what these cells are.
SOURCE : NEWS SCIENTIST MAGAZINE NOVEMBER 2011

Pull Out Photons From Empty Space

You can get something from nothing — as long as you are moving close to the speed of light. The discovery confirms a 41-year-old prediction on how to pull energy from empty space and produce light.
The phenomenon relies on the long-established fact that empty space is not at all empty, but fizzing with particles that pop in and out of existence. This is down to the laws of quantum mechanics, which say that even a vaccum cannot have exactly zero energy but must exhibit small fluctuations of energy. These fluctuations show themselves as pairs of short-lived particles.
The presence of these "virtual" particles, usually photons, has long been proved in experiments demonstrating the standard Casimir effect, in which two parallel mirrors set close together I' will feel a pull towards each other. This happens because the small space between the mirrors limits the number of virtual photons that can appear in this region. Since there are more photons outside this space, the radiation pressure on the mirrors from the outside is larger than the pressure between them, which pushes the mirrors together.
Now Chris Wilson at Chalmers University of Technology in Gothenburg, Sweden, and his colleagues have gone a step further, pulling photons out of the void in a process called the dynamical Casimir effect. "It was a difficult technical experiment," says Wilson. "We were very happy when it worked."
The effect needs only a single metal mirror, but it must move at close to the speed of light through the sea of virtual photons in empty space. Because the mirror is a conductor, the photons — which are electromagnetic particles — will absorb some of its kinetic energy. They then radiate this extra energy by producing pairs of real photons.
Clearly, moving a mirror at close to light speed is impractical. So the researchers used a superconducting electrical circuit with an oscillator that rapidly alters the distance an electron must travel through the circuit.
The electron's movement is determined by the location at which the circuit's electric field falls to zero. To control the circuit's characteristics, the team used a superconducting quantum interference device. With this SQUID they were able to change the distance from the electron to the zero-field location so quickly that the electron appeared to move at a quarter of the speed of light. This was fast enough for the circuit to emit real photons (Nature, DOI: 10.1038/ natureto561). "Particles were produced in pairs, coming right out of the vacuum," Wilson says.
"This is a significant breakthrough," says Diego Dalvit, a physicist at the Los Alamos National Laboratory in New Mexico. The energy of virtual photons is cosmologists' best guess of what lies behind the dark energy that is causing the universe's expansion to accelerate. The experiment will open possibilities for doing table-top experiments of cosmology", Dalvit says.
SOURCE : NEW SCIENTIST MAGAZINE NOVEMBER 2011

Thursday, November 17, 2011

Malaria's Nemesis

FORTY years ago a secret military project In communist China yielded one of the greatest drug discoveries in modern medicine. Artemisinin remains the most effective treatment for malaria today and has saved millions of lives. Until recently, though, the drug's origins were a mystery.
"I was at a meeting in Shanghai in 2005 with all of the Chinese inalariologists and tasked who discovered artemisinin," says Louis Miller, a malaria researcher at the US National Institutes of Health in Rockville, Maryland. "I was shocked that no one knew." Miller and his NIH colleage Xinzhuan Su began digging into the drug's history. After reviewing letters, researchers' original notebooks and transcripts from once-secret meetings, they concluded the major credit should go to pharmacologist Tu Youyou. Two months ago In received America's top medical accolade, the Lasker award. Now 80, Tu still runs a lab in Beijing where she continues to study artemisinin. Shortly before receiving the award she met me at a hotel near New York's Central Park.
Joining us was her son-in-law, Lei Mao, a physician living in North Carolina, who served as interpreter. Tu is a diminutive figure with short, jet black hair that curls in wisps around her cars. Reading glasses dangle from a chain around her neck. On responding to any kind of praise she is softly spoken and painfully modest. Talking about her research, however, she speaks with an urgency and passion undimmed by passing years. Ttt carried out her work in the 19605 and 705 at the height of China's Cultural Revolution, a government-imposed attempt to forge a new kind of society according to its notion of socialism. It was a chaotic and frightening time, when scientists and other intellectuals were seen as class enemies and arbitrarily sent to work in the countryside for "re-education". 
Scientific publication was forbidden. Yet China had a pressing need that trumped any political cause. One of its few allies, North Vietnam, was at war with South Vietnam and its US ally, and malaria was rampant in the region. At the time t he primary treatment was a drug called chloroquine, but the malaria parasite was rapidly evolving resistance. The country was losing more soldiers to malaria than to American bullets. China's leader Mao Zedong set up a secret drug discovery project, known only as 523, for the date it was launched: 23 May 1967. Within a couple of years hundreds of scientists had tested thousands of synthetic compounds without success and it was common knowledge that a similar programme in the US had drawn a blank too. With no synthetic drugs forthcoming. attention turned to China's traditional medicines. The government asked the Academy of Traditional Chinese Medicine in Beijing to appoint one of its researchers to scour China's herb garden for a cure. 
The academy chose Tu, a mid-career scientist who had studied both Chinese and western medicine and knew enough about both to realise it would not be an easy job. "By the time I started my search over 240,000 compounds had been screened in the US and China without any positive results," she says. Soon after joining project 523, Tu was sent to Hainan province, a region in the far south long plagued by malaria, to observe the effects of the disease firsthand. As 'fuss husband had been banished to the countryside at the time, she had to entrust her 4-year-old daughter to the care of a local nursery. On Tu's return to Beijing six months later, her daughter did n't recognise her a ml hid from the "strange woman" who came to take her home. But Ti seems to bear no bitterness. "The work was the top priority, sol was certainly willing to sacrifice my personal life," she says. And her time in Hainan had made a big impression. "I saw a lot of children who were in the latest stages of malaria." Tu says. "Those kids died very quickly." She and three assistants reviewed more than 2000 recipes for traditional Chinese remedies in the academy's library. 'They made 380 herbal extracts and tested them on mice. One of the compounds did indeed reduce the number of malaria parasites in the blood. It was derived from sweet wormwood (Artemisia a arum), a plant common throughout China, which was in a treatment for "intermittent fevers"— a hallmark of malaria. 
The team carried out further tests, only to be baffled when the compound's powers seemed to melt away. Tu reread the recipe, written more than 1600 years ago in a text appositely titled "Emergency Prescriptions Kept Up One's Sleeve". The directions were to soak one bunch of wormwood in water and then drink the juice. Tu realised that their method of preparation, boiling up the wormwood, might have damaged the active ingredient. So she made another preparation using an ether solvent, which boils at 35°C. When tested on mice and monkeys, it proved too per cent effective. "We had just cured drug-resistant malaria," Tu says. "We were very excited." But would it work in humans—and was it safe? Tu volunteered to be the first test subject. "As the head of this research group, I had t he responsibility," she says. After suffering no ill effects, Tu began clinical trials with labourers who had contracted malaria in the forest. Within 30 hours their fevers had subsided and parasites were gone from their blood. Tu's work wasn't published until Pm, after the turmoil of the Cultural Revolution had died down. 
As was customary, the authors remained anonymous; in such an egalitarian society the group was considered more Important than the individual. The discovery of artemisinin remains a point of pride for China, and some argue it shows the worth of scouring herbal lore for other botanical buried gems. The drug now helps tens of millions of people a year, and it is still obtained from sweet wormwood, grown in China. Vietnam and cast Africa. Research is ongoing to breed strains with higher yields of the active compound. n the past decade the first resistance to artemisinin has emerged, in Cambodia.The drug still works but it takes longer, typically four days instead of two. To stop resistance from spreading further doctors now only use artemisin in in combination with another antimalarial; it is harder for the parasite to evolve resistance to two drugs simultaneously. As Tu says, malaria researchers have to remain vigilant.
"It is scientists responsibility to continue fighting for the healthcare of all humans?' And despite the importance of her work, she is modest. "What I have done was what I should have done as a return for the education provided by my country," she says. She expressed gratitude at the Lasker award ceremony, with her husband, daughter and granddaughter at her side. But that was just the icing on the cake: "I feel more reward when I see so many patients cured?"
SOURCE : NEW SCIENTIST MAGAZINE NOVEMBER 2011

Related Posts Plugin for WordPress, Blogger...

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Affiliate Network Reviews